🔎 Trials Near Me

Gara Jalqabaatti › Myasthenia Gravis › California

Qorannoo klinikaalii Myasthenia Gravis California keessatti

Qorannoo 20 Myasthenia Gravis f California keessatti hirmaatuu jiru.

Magaalota California keessatti

Takkalaa qorannoo (Ingiliffa)

Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

  • Neurology Center of North Orange County, Fullerton
  • The Neurology Group, Pomona
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07217587

A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)

  • Cinical Study Site, Pasadena
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07647510

ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

  • Profound Research LLC - Carlsbad, Carlsbad
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07294170

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

  • Profound Research LLC - Carlsbad, Carlsbad
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07284420

A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis

  • Tri Valley Neurology Medical Associates Inc., Mission Hills
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07501702

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

  • TG Therapeutics Investigational Trial Site, La Jolla
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06680037

Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis

  • University of California Irvine Medical Center, Irvine
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Hag-2026 · NCT06414954

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

  • Hoag Memorial Hospital Presbyterian, Newport Beach
  • Stanford Neuroscience Health Center, Palo Alto
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT07304154

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

  • University of California Irvine, Orange
  • UC Davis, Department of Neurology, Sacramento
  • University of California, San Francisco, San Francisco
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 13-Hag-2026 · NCT06359041

Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)

  • University of California-San Francisco, San Francisco
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 hanga 64 · Dubartoota · Haaromfame 11-Hag-2026 · NCT06940323

Study of Aritinercept in Patients With Generalized Myasthenia Gravis

  • Aurinia Investigational Site, Pasadena
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT07596901

A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis

  • Lucile Packard Children's Hospital Stanford, Palo Alto
  • UCSF Benioff Children's Hospital, San Francisco
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT05265273

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

  • Site Number - 1010, Carlsbad
  • Site Number - 1028, Irvine
  • Site Number - 1023, Los Angeles
  • fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT07039916

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

  • Ronald Reagan UCLA Medical Center, Los Angeles
  • University of California, Irvine, Orange
  • Stanford University Medical Center, Palo Alto
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT06193889

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

  • Care Access Research, Pasadena
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT04951622

A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

  • University of Southern California, Los Angeles
  • University of California Irvine, Orange
  • University of California San Francisco (UCSF), San Francisco
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Wax-2026 · NCT06456580

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

  • UCLA Medical Center, Los Angeles
  • University of California, Irvine, Orange
  • Stanford Hospital, Palo Alto
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Gur-2026 · NCT06626919

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

  • Clinical Trial Site, Fresno
  • Clinical Trial Site, Orange
  • Clinical Trial Site, Rancho Mirage
  • fi 1 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Gur-2026 · NCT04202341

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

  • UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Brain Tumor Center,, San Francisco
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Gur-2026 · NCT06298565

Vitaccess Real MG Registry

  • UCI Health, Orange
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ado-2025 · NCT06064461

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.